NCT02226484View on ClinicalTrials.gov

Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD?

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

June 30, 2016

Conditions
Gastroesophageal Reflux DiseaseGERDAcid RefluxReflux
Interventions
DRUG

Quercetin

Two 250 mg capsules of quercetin twice-a-day one hour before meals with a glass of water.

Trial Locations (1)

27599

UNC Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT02226484 - Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? | Biotech Hunter | Biotech Hunter